Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Singh, Ajaypal

One or more keywords matched the following items that are connected to Singh, Ajaypal

Item Type	Name
Concept	Hematinics
Academic Article	The benefits of IV iron therapy in treating anemia in patients with renal disease and comorbid cardiovascular disease.
Academic Article	Correction of anemia with epoetin alfa in chronic kidney disease.
Academic Article	Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study.
Academic Article	Anaemia of CKD--the CHOIR study revisited.
Academic Article	The FDA black box for EPO: what should nephrologists do?
Academic Article	Hemoglobin maintenance with use of extended dosing of epoetin alfa in patients with diabetes and anemia of chronic kidney disease.
Academic Article	Is it time to reconsider subcutaneous administration of epoetin?
Academic Article	Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
Academic Article	Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease.
Academic Article	The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
Academic Article	Ferric gluconate treatment provides cost savings in patients with high ferritin and low transferrin saturation.
Academic Article	Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article	A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
Academic Article	Does TREAT give the boot to ESAs in the treatment of CKD anemia?
Academic Article	The FDA's perspective on the risk for rapid rise in hemoglobin in treating CKD anemia: Quo Vadis.
Academic Article	ESAs in dialysis patients: are you a hedgehog or a fox?
Academic Article	Should we keep hemoglobin levels as a viable outcome measure?
Academic Article	Debate: PRO Position. Should hemoglobin targets for anemic patients with chronic kidney disease be changed?
Academic Article	Diabetes, anemia and CKD: Why TREAT?
Academic Article	The etiology of anemia in heart failure. Preface.
Academic Article	Therapy with erythropoiesis-stimulating agents and renal and nonrenal outcomes.
Academic Article	Anemia in chronic kidney disease: new advances.
Academic Article	Message to the FDA on ESAs: REMS is not enough, more studies are needed.
Academic Article	What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?
Academic Article	Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
Academic Article	Is there a deleterious effect of erythropoietin in end-stage renal disease?
Academic Article	Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
Academic Article	Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents.
Academic Article	Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.
Academic Article	Anaemia: Does the KDIGO guideline move the needle in CKD anaemia?
Academic Article	Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Academic Article	Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.
Academic Article	How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The itsy bitsy anemia problem.
Academic Article	Cause of Death in Patients With Diabetic CKD Enrolled in the?Trial to Reduce Cardiovascular Events With Aranesp Therapy?(TREAT).
Academic Article	Ferric pyrophosphate citrate (Triferic?) administration via the dialysate maintains hemoglobin and iron balance in chronic hemodialysis patients.
Academic Article	C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article	A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
Academic Article	Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Academic Article	Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial.
Academic Article	Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
Academic Article	Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Academic Article	The ASCEND-ND trial: study design and participant characteristics.
Academic Article	Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial.
Academic Article	Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials.
Academic Article	Regional Variation of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Global Daprodustat Dialysis Study (ASCEND-D).
Academic Article	The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease.
Academic Article	Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.

Search Criteria

Hematinics